Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study

scientific article published on October 2017

Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JNCI/DJX051
P932PMC publication ID5939625
P698PubMed publication ID28521362

P50authorRoy E ShoreQ37837423
Anne ReinerQ45633818
Esther M. JohnQ59752419
Leslie BernsteinQ60607806
Julia A. KnightQ78316584
Daniel StramQ85936408
Meghan WoodQ88561122
David DugganQ95992037
Kathleen E. MaloneQ110376035
Jonine L BernsteinQ114337788
WECARE Study Collaborative GroupQ117253025
P2093author name stringCharles F Lynch
Robert W Haile
Duncan C Thomas
Jennifer D Brooks
Susan A Smith
Xiaolin Liang
Lene Mellemkjaer
Mark E Robson
Patrick J Concannon
P2860cites workA flexible and accurate genotype imputation method for the next generation of genome-wide association studiesQ21129496
Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatmentQ23922894
PLINK: a tool set for whole-genome association and population-based linkage analysesQ24677407
Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE studyQ24794680
Principal components analysis corrects for stratification in genome-wide association studiesQ27860975
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSQ28584533
Large-scale genotyping identifies 41 new loci associated with breast cancer riskQ29416989
Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology StudyQ30415050
Rare germline mutations in PALB2 and breast cancer risk: a population-based studyQ30417260
Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) StudyQ30427359
Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE studyQ30432062
Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.Q30432372
Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology studyQ30432746
Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE StudyQ30438623
Variants in the ATM gene associated with a reduced risk of contralateral breast cancerQ30438940
Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.Q33576049
Epidemiology of contralateral breast cancerQ33766634
Rare variants in the ATM gene and risk of breast cancerQ35608690
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerQ35996692
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancerQ36449203
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancerQ37373918
Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional surveyQ37669779
Review of risk factors for the development of contralateral breast cancer.Q38135570
Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis.Q38281709
Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer.Q54780478
P433issue10
P407language of work or nameEnglishQ1860
P577publication date2017-10-01
P1433published inJournal of the National Cancer InstituteQ400279
P1476titleAssociation of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study
P478volume109

Reverse relations

cites work (P2860)
Q90327632Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer
Q57420847Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study
Q89746441Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field
Q64279327Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk
Q89919334Machine learning on genome-wide association studies to predict the risk of radiation-associated contralateral breast cancer in the WECARE Study
Q90049987Radiogenomic Predictors of Adverse Effects following Charged Particle Therapy

Search more.